ArticleDiscover oncology2025

Glutaryl-CoA dehydrogenase (GCDH) enhances renal malignancy risk via modulating glutarylcarnitine levels.

Xuanshuo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.